| [1] |
Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program[J]. J Glob Antimicrob Resist, 2016, 5:36–41.
|
| [2] |
唐贞明. 医院与社区获得性肺炎的病原菌分布及耐药性[J]. 中华医院感染学杂志, 2014, 24(5):1092–1094.
|
| [3] |
Xie DS, Xiong W, Xiang LL, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007-2008[J]. J Hosp Infect, 2010, 76(2):150–155.
|
| [4] |
Barbier F, Andremont A, Wolff M, et al. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management[J]. Curr Opin Pulm Med, 2013, 19(3):216–228.
|
| [5] |
Bos LD, Martin-Loeches I, Kastelijn JB, et al. The volatile metabolic fingerprint & of ventilator-associated pneumonia[J]. Intensive Care Med, 2014, 40(5):761–762.
|
| [6] |
Shaw AG, Vento TJ, Mende K, et al. Detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus colonization of healthy military personnel by traditional culture, PCR, and mass spectrometry[J]. Scand J Infect Dis, 2013, 45(10):752–759.
|
| [7] |
Pugh R, Grant C, Cooke RP, et al. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults[J]. Cochrane Database Syst Rev, 2015, (8):CD007577.
|
| [8] |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2):165–228.
|
| [9] |
Zagli G, Cozzolino M, Terreni A, et al. Diagnosis of ventilator-associated pneumonia: a pilot, exploratory analysis of a new score based on procalcitonin and chest echography[J]. Chest, 2014, 146(6):1578–1585.
|
| [10] |
Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa[J]. J Antimicrob Chemother, 2013, 68(10):2286–2290.
|
| [11] |
Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit[J]. Am J Respir Crit Care Med, 2014, 189(10):1225–1233.
|
| [12] |
Imberti R, Cusato M, Villani P, et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after Ⅳ colistin methanesulfonate administration[J]. Chest, 2010, 138(6):1333–1339.
|
| [13] |
Gautret P, Gray GC, Charrel RN, et al. Emerging viral respiratory tract infections-environmental risk factors and transmission[J]. Lancet Infect Dis, 2014, 14(11):1113–1122.
|
| [14] |
Feng WL, Yang J, Xi ZQ, et al. Epidemiologic study on patients with invasive fungal infections[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2009, 30(10):1043–1046.
|
| [15] |
Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes[J]. Clin Infect Dis, 2008, 46(2):201–211.
|
| [16] |
Hamet M, Pavon A, Dalle F, et al. Candida spp. Airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia[J]. Intensive Care Med, 2012, 38(8):1272–1279.
|
| [17] |
Xu H, Li L, Huang WJ, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China[J]. Clin Microbiol Infect, 2012, 18(4):403–408.
|
| [18] |
Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015, 78:7–15.
|
| [19] |
Hsu LY, Lee DG, Yeh SP. Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study[J]. Clin Microbiol Infect, 2015, 21(6):594.e7–11.
|